Skip to content

Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02224170
Enrollment
8
Registered
2014-08-25
Start date
2014-11-30
Completion date
2015-03-31
Last updated
2019-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic Gallstones Without Cholecystitis, Gallbladder Polyp

Keywords

Dexamethasone, Lidocaine, Quality of Recovery, Laparoscopic cholecystectomy

Brief summary

The primary purpose of this study is to compare the effect of lidocaine and dexamethasone on postoperative quality of recovery after laparoscopic cholecystectomy

Interventions

DRUGLidocaine

Lidocaine 2mg Kg-1 in normal saline (total volume 25mL) was infused after tracheal intubation, and lidocaine was infused at the rate of lidocaine 2mg Kg-1 h-1 (0.2 ml Kg-1 h-1, equivalent volume as normal saline in dexamethasone group) until the end of surgery (at the time of skin closure).

DRUGDexamethasone

Dexamethasone 8mg in normal saline (total volume 25mL) was infused after tracheal intubation, and normal saline was continuously infused at the rate of 0.2 ml Kg-1 h-1 until the end of surgery (at the time of skin closure).

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II patients aged between 20 and 65 year undergoing laparoscopic cholecystectomy due to gallbladder polyp or asymptomatic gallstones without cholecystitis

Exclusion criteria

1. Steroid therapy or immunocompromised patients 2. Diabetes mellitus 3. Allergy to lidocaine or dexamethasone 4. Severe renal dysfunction (serum creatinine more than 1.6mg/dl) 5. Severe liver disease ( liver enzymes more than two times normal values) 6. History of atrioventricular block 7. Have a difficulty in understanding QoR-40 (40-item quality-of-recovery scoring system) or Korean language 8. History of physicologic disease

Design outcomes

Primary

MeasureTime frameDescription
QoR-40 scorefrom baseline to 3 hours on the day after surgery40-item quality-of-recovery scoring system

Secondary

MeasureTime frameDescription
Incidence and severity of postoperative nausea and vomitingfrom baseline to 3 hours on the day after surgery10 cm-visual analogue scale

Other

MeasureTime frameDescription
Time to first analgesic requestfrom baseline to 3 hours on the day after surgery
Number of rescue pain relieverfrom baseline to 3 hours on the day after surgery
Severity of postoperative painfrom baseline to 3 hours on the day after surgery10 cm-visual analogue scale

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026